Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Urofollitropin IP (150 IU) Injection
Therapeutic Category
Gynecology and Fertility
Dosage Form
Injection
Packaging Type
Vial
Packaging
150 IU
Price
₹1995/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Fertiedge FSH 150 Injection contains Urofollitropin, a purified form of the follicle-stimulating hormone (FSH) that helps in the development of healthy eggs in women and sperm in men. It is mainly used in fertility treatments to stimulate the ovaries to produce multiple eggs for procedures like in-vitro fertilization (IVF). In men, it may be used to improve sperm production in certain conditions. The injection is given under medical supervision, usually by a doctor or trained nurse.
May cause abdominal discomfort, bloating, mild pain at the injection site, headache, mood changes, or breast tenderness. Rarely, it can lead to ovarian hyperstimulation syndrome (OHSS), which requires immediate medical attention.
Treatment of female infertility due to low FSH levels Ovarian stimulation in assisted reproductive techniques like IVF or ICSI Treatment of male infertility caused by low sperm production due to hormonal issues
Fertiedge FSH 150 Injection should only be used under the supervision of a fertility specialist. Doses and treatment duration depend on the patient’s condition and response. Avoid self-administration.
Store in a refrigerator at 2°C to 8°C. Do not freeze. Protect from light. Keep out of reach of children.
Composition : Human chorionic gonadotropin (hCG) (10000units) Injection
Composition : Ashwgandha Ext 90 mg + Shatavari 90mg + Safed musli 90mg + Horny Goat Weed 80mg + Tribulus terestris 50 mg + Fenugreek 30 mg + Mucuna pruriens 40 mg + Shilajit. 30 mg
Composition : Urofollitropin (75IU) Injection
Composition : Human chorionic gonadotropin (hCG) (5000units)
Composition : Menotrophin (75IU)
Composition : Astaxanthin (16mg) + Reduced Coenzyme Q10 (200mg)
Composition : Micronised Dehydroepiandrosterone 75mg + Melatonin 3mg + Ubidecarenone (Coezyme Q10) 100mg (DRUG)
Composition : Coenzyme Q10 100mg + DHA 10% 90mg + Melatonin 2mg + Chromium Picolinate 200mcg + N-acetyl L-cysteine 50mg + L-arginine 25mg + Zinc 15mg + Folic Acid 176.46mcg + Selenium 40mcg + Iodine 50mcg + Vitamin C 40mg + Vitamin A 1000 IU + Vitamin D3 400 IU + Vitamin B12 1mcg
Composition : Astaxanthin 8mg, Coenyme Q10 10 mg, L-Carnitine L- Tartrate 500mg ,Vitamin k27 50 mcg, Magnesium sulphate 50 mg and Zinc sulphate 7.5 mg
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Urofollitropin IP 150 IU Injection has strong demand in the fertility, gynecology, reproductive medicine, and IVF segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on infertility and specialty healthcare portfolios.
Medical distributors and agencies can benefit from consistent demand for controlled ovarian stimulation and infertility treatment under specialist medical supervision. Urofollitropin IP 150 IU is a highly purified human follicle-stimulating hormone (FSH) used to stimulate follicular development in women undergoing fertility treatment Commonly prescribed for ovulation induction in women with anovulation or oligo-ovulation and for controlled ovarian stimulation in assisted reproductive technology (ART) procedures, including in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI), as advised by fertility specialists Helps promote the growth and maturation of ovarian follicles, increasing the likelihood of successful ovulation and oocyte retrieval when used as part of a fertility treatment protocol Administered by subcutaneous or intramuscular injection, with the dose individualized according to the patient's ovarian response and treatment protocol Requires close specialist supervision with regular monitoring through ultrasound examinations and serum estradiol levels to optimize treatment outcomes and minimize the risk of ovarian hyperstimulation syndrome (OHSS) and multiple pregnancies Frequently utilized in fertility clinics, IVF centers, gynecology departments, and reproductive medicine hospitals Widely prescribed by fertility specialists, reproductive endocrinologists, and gynecologists experienced in infertility management This strengthens a comprehensive fertility and assisted reproductive healthcare portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Urofollitropin IP 150 IU Injection with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from growing demand in the fertility and IVF market, specialty institutional procurement opportunities, reliable supply chain support, repeat business, and attractive margins in the reproductive medicine segment.
Interested distributors, stockists, wholesalers, and institutional suppliers can partner with Cafoli LifeCare Pvt Ltd to access lucrative PCD pharma franchise opportunities across India. With exclusive monopoly rights, extensive promotional support, high-quality fertility and specialty healthcare products, attractive business margins, and dependable logistics support, Cafoli LifeCare Pvt Ltd helps franchise partners build a successful and profitable pharmaceutical business.